Drug Trial Radar · NCT07336641
LANDSCAPE: Demographics and Treatment Patterns of Patients With Immune-Mediated Inflammatory Skin Diseases in Italian Clinical Practice
Last checked: Nov 20, 2026Latest source record: Jan 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
20,000
Planned (sponsor's estimate)
Start
Jan 2026
Primary completion
May 2026
Study completion Jan 2028
Sponsor
- Lead sponsor
- Fondazione ISIDEAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jan 13, 2026
Design
- Study type
- Observational
- FDA-regulated drug
- No
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This multicenter retrospective observational registry study will collect existing clinical data from Italian centers to describe epidemiology, treatment patterns, clinical evolution, safety, and comorbidities in patients aged 12 years and older with psoriasis, atopic dermatitis, vitiligo, alopecia areata, or hidradenitis suppurativa.
Conditions
- Psoriasis
- Atopic Dermatitis
- Vitiligo
- Alopecia Areata
- Hidradenitis Suppurativa
Interventions
Conventional Systemic TherapiesDrug
Retrospective observation of conventional systemic treatments prescribed in routine clinical practice, including but not limited to methotrexate, cyclosporine, acitretin, and other conventional agents. No drugs are administered as part of this study; treatment data are collected from existing medical records.
Biologic TherapiesDrug
Retrospective observation of biologic treatments prescribed in routine clinical practice, including but not limited to TNF-α inhibitors, IL-17 inhibitors, IL-23 inhibitors, IL-4/IL-13 inhibitors, and JAK inhibitors. No drugs are administered as part of this study; treatment data are collected from existing medical records.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Patient Distribution by Disease TypeTime frame: January 2016 to December 2025
- Age at Treatment InitiationTime frame: January 2016 to December 2025
- Sex DistributionTime frame: January 2016 to December 2025
Locations
1 site in 1 country. Site status is shown where the registry gives one.
IRCCS Istituto Clinico Humanitas - Dermatology Unit
Rozzano, Lombardy, Italy
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.